Related field:
When transfemoral access is required, optimising your vascular access and closure is proven to reduce complications that may enable same-day discharge
The use of ultrasound significantly reduces the rate of vascular access site complications vs no ultrasound1
Our introducers with seamless sheath transitions avoid irritation of the artery & minimize vascular access trauma2
Our Nitinol hydrophilic guide wire are designed to direct a catheter to the desired anatomical location
Our hydrophilic coating provides a good combination of navigability and control.
Our VCD actively seal the arteriotomy to provide safe and effective closure3,4 while enabling early ambulation5,6
Routine real-time US guidance proved to reduce the number of attempts, time to access, risk of venipunctures, and vascular complications in femoral arterial access.
AH Seto et al. JACC Cardiovasc Interv (2010)
After more than 20 years on the market and numerous randomized clinical trials, Angio-Seal™ VIP proved to be safe & effective closure of the femoral access site.
In patients undergoing lower-limb arterial endovascular revascularization, FemoSeal™ was superior to ProGlide™ in terms of technical success.
Y Gouëffic et al. Cardiovasc Intervent Radiol (2021)
Interviewed physicians believed that atraumatic navigation through the vessels, high trackability and good crossability are highly relevant to their procedural success and efficiency.
By ensuring fast hemostasis, shortening bed rest and accelerating hospital discharge, Vascular Closure Devices facilitate your performance of endovascular procedures on an ambulatory basis.
Terumo Interventional Systems is focused on bringing access & closure to the forefront of clinical practice. Our product portfolio, clinical research, and collaborative educational programs have helped thousands of healthcare providers advance interventional care and benefited to millions of patients.
Looking to the future, we remain fully committed to improving patient's quality of life by supporting both radial & femoral interventional procedures
1 Rashid MK et al. J Invasive Cardiol 2019;31:E192–8
2 Allie DE et al. Cath Lab Digest 2009;17:1
3 Schulz-Schüpke et al. JAMA, 312(19), 2014.
4 Wong H.F. et al. Am J Neuroradiol. 2013; 34: 397-401.
5 Cox T. et al. Surg Technol Int. 2015 Nov
6 Martin J.L. et al. Catheter Cardiovasc Interv. 2008 Jan 1;71(1):1-5
7 Manolis S, et al. Indian Heart Journal. 2016;68:529-38.
8 Interventional Cardiology Devices | Market Insights | Europe | 2023
9 Vascular Closure Devices | Market Insights | Global | 2023
Our sales representatives are here for you.
This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.
This webpage can include promotional content regarding one or several products... of Terumo Europe, or some procedures concerning the use or implantation of such products.This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public. For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.
This is HCP only content
